Stay ahead in cardiovascular care with the latest 2024 HCM guideline updates. This course empowers you to confidently apply diagnostic and pharmacologic advancements while integrating shared decision-making and multidisciplinary care to enhance patient outcomes.
Learning Objectives
- Describe key updates in the 2024 HCM guideline including appropriate diagnostic and pharmacologic therapy.
- Integrate shared decision-making, appropriate referral for ICD evaluation, exercise counseling, and multidisciplinary care into practice.
CE certificate available upon successful completion of the post-test and program evaluation.
Accreditation:
PCNA is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 030602. This activity is approved for 0.5 contact hour(s) (which includes 0.25 hour(s) of pharmacology).
